Irina Kalatskaya, PhD
Irina Kalatskaya, PhD
Associate Scientific Director, EMD Serono Research and Development Institute
Zweryfikowany adres z oicr.on.ca - Strona główna
Cytowane przez
Cytowane przez
Reactome: a database of reactions, pathways and biological processes
D Croft, G O’kelly, G Wu, R Haw, M Gillespie, L Matthews, M Caudy, ...
Nucleic acids research 39 (suppl_1), D691-D697, 2010
AMD3100 is a CXCR7 ligand with allosteric agonist properties
I Kalatskaya, YA Berchiche, S Gravel, BJ Limberg, JS Rosenbaum, ...
Molecular pharmacology 75 (5), 1240-1247, 2009
Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer
Y Kim, V Ignatchenko, CQ Yao, I Kalatskaya, JO Nyalwidhe, RS Lance, ...
Molecular & Cellular Proteomics 11 (12), 1870-1884, 2012
Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells
JA Sprowl, K Reed, SR Armstrong, C Lanner, B Guo, I Kalatskaya, L Stein, ...
Breast Cancer Research 14, 1-18, 2012
Mutation of tyrosine in the conserved NPXXY sequence leads to constitutive phosphorylation and internalization, but not signaling, of the human B2 bradykinin receptor
I Kalatskaya, S Schussler, A Blaukat, W Muller-Esterl, M Jochum, D Proud, ...
Journal of Biological Chemistry 279 (30), 31268-31276, 2004
ISOWN: accurate somatic mutation identification in the absence of normal tissue controls
I Kalatskaya, QM Trinh, M Spears, JD McPherson, JMS Bartlett, L Stein
Genome medicine 9, 1-18, 2017
Early G1 Cyclin-Dependent Kinases as Prognostic Markers and Potential Therapeutic Targets in Esophageal Adenocarcinoma
A Ismail, S Bandla, M Reveiller, L Toia, Z Zhou, WE Gooding, I Kalatskaya, ...
Clinical Cancer Research 17 (13), 4513-4522, 2011
Detection of circulating tumor DNA in plasma: a potential biomarker for esophageal adenocarcinoma
M Egyud, M Tejani, A Pennathur, J Luketich, P Sridhar, E Yamada, ...
The Annals of thoracic surgery 108 (2), 343-349, 2019
Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation
M Yu, G Lin, N Arshadi, I Kalatskaya, B Xue, S Haider, F Nguyen, ...
Molecular and cellular biology, 2012
Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer
M Egyud, P Sridhar, A Devaiah, E Yamada, S Saunders, A Ståhlberg, ...
Head & neck 41 (5), 1351-1358, 2019
The role of helix 8 and of the cytosolic C‐termini in the internalization and signal transduction of B1 and B2 bradykinin receptors
A Faussner, A Bauer, I Kalatskaya, S Schüssler, C Seidl, D Proud, ...
The FEBS journal 272 (1), 129-140, 2005
Downregulation of bradykinin B2 receptor in human fibroblasts during prolonged agonist exposure
A Blaukat, P Micke, I Kalatskaya, A Faussner, W Müller-Esterl
American Journal of Physiology-Heart and Circulatory Physiology 284 (6 …, 2003
Overview of major molecular alterations during progression from Barrett's esophagus to esophageal adenocarcinoma
I Kalatskaya
Annals of the New York Academy of Sciences 1381 (1), 74-91, 2016
Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer
M Braunstein, L Liao, N Lyttle, N Lobo, KJ Taylor, PM Krzyzanowski, ...
Breast cancer research 18, 1-16, 2016
Bile exposure inhibits expression of squamous differentiation genes in human esophageal epithelial cells
M Reveiller, S Ghatak, L Toia, I Kalatskaya, L Stein, M D'Souza, Z Zhou, ...
Annals of surgery 255 (6), 1113-1120, 2012
Expression levels strongly affect ligand-induced sequestration of B2 bradykinin receptors in transfected cells
A Faussner, A Bauer, I Kalatskaya, M Jochum, H Fritz
American Journal of Physiology-Heart and Circulatory Physiology 284 (6 …, 2003
Interruption of the ionic lock in the bradykinin B2 receptor results in constitutive internalization and turns several antagonists into strong agonists
J Leschner, G Wennerberg, J Feierler, M Bermudez, B Welte, I Kalatskaya, ...
Journal of Pharmacology and Experimental Therapeutics 344 (1), 85-95, 2013
Splicing arrays reveal novel RBM10 targets, including SMN2 pre-mRNA
LC Sutherland, P Thibault, M Durand, E Lapointe, JM Knee, A Beauvais, ...
BMC molecular biology 18, 1-14, 2017
Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma
Z Zhou, I Kalatskaya, D Russell, N Marcon, M Cirocco, PM Krzyzanowski, ...
Clinical and experimental gastroenterology, 219-229, 2019
Pathprinting: An integrative approach to understand the functional basis of disease
GM Altschuler, O Hofmann, I Kalatskaya, R Payne, SJ Ho Sui, U Saxena, ...
Genome medicine 5, 1-13, 2013
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20